142 related articles for article (PubMed ID: 27916547)
21. Multi-analyte analysis of cytokines that predict outcomes in patients with hepatocellular carcinoma treated with radiotherapy.
Cha H; Lee EJ; Seong J
World J Gastroenterol; 2017 Mar; 23(11):2077-2085. PubMed ID: 28373775
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic and prognostic validity of Golgi protein 73 in hepatocellular carcinoma.
Ozkan H; Erdal H; Tutkak H; Karaeren Z; Yakut M; Yüksel O; Köklü S
Digestion; 2011; 83(1-2):83-8. PubMed ID: 21042019
[TBL] [Abstract][Full Text] [Related]
23. Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large-scale, multicentre study.
Shen Q; Fan J; Yang XR; Tan Y; Zhao W; Xu Y; Wang N; Niu Y; Wu Z; Zhou J; Qiu SJ; Shi YH; Yu B; Tang N; Chu W; Wang M; Wu J; Zhang Z; Yang S; Gu J; Wang H; Qin W
Lancet Oncol; 2012 Aug; 13(8):817-26. PubMed ID: 22738799
[TBL] [Abstract][Full Text] [Related]
24. Influence of hepatitis C virus infection on circulating levels of sICAM-1 and VEGF in patients with hepatitis C and hepatocellular carcinoma (HCC) and their role in enhancing detection of HCC.
Helaly GF; Abou Shamaa LA
Egypt J Immunol; 2006; 13(1):27-38. PubMed ID: 17974148
[TBL] [Abstract][Full Text] [Related]
25. CXCL13 rather than IL-31 is a potential indicator in patients with hepatocellular carcinoma.
Li B; Su H; Cao J; Zhang L
Cytokine; 2017 Jan; 89():91-97. PubMed ID: 27663978
[TBL] [Abstract][Full Text] [Related]
26. Clinical significance of serum vascular cell adhesion molecule-1 levels in patients with hepatocellular carcinoma.
Ho JW; Poon RT; Tong CS; Fan ST
World J Gastroenterol; 2004 Jul; 10(14):2014-8. PubMed ID: 15237425
[TBL] [Abstract][Full Text] [Related]
27. Plasma proteosome level as a potential marker for hepatocellular carcinoma.
Salama HM; Abdel-Haleem H; Taha FM; Abdel-Azeez RA; Marzaban RN; El-Nahaas SM; Darwish T
Arab J Gastroenterol; 2013 Sep; 14(3):87-93. PubMed ID: 24206735
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical Coexpression of Epithelial Cell Adhesion Molecule and Alpha-Fetoprotein in Hepatocellular Carcinoma.
Lima LDP; Machado CJ; Rodrigues JBSR; Vasconcellos LS; Junior EP; Vidigal PVT; Resende V
Can J Gastroenterol Hepatol; 2018; 2018():5970852. PubMed ID: 30112355
[TBL] [Abstract][Full Text] [Related]
29. Clinical relevance of serum endoglin level in Egyptian hepatocellular carcinoma patients.
Elnemr DM; Abdel-Azeez HA; Labib HA; Abo-Taleb FM
Clin Lab; 2012; 58(9-10):1023-8. PubMed ID: 23163119
[TBL] [Abstract][Full Text] [Related]
30. [Serum anti-Ku86: a potential biomarker for early detection of hepatocellular carcinoma].
Chu L; Zhang X; Wang G; Zhou W; Du Z; Liu A; Zhao H
Zhonghua Zhong Liu Za Zhi; 2014 Feb; 36(2):123-7. PubMed ID: 24796461
[TBL] [Abstract][Full Text] [Related]
31. Feasibility of α-fetoprotein as a diagnostic tool for hepatocellular carcinoma in Korea.
Ahn DG; Kim HJ; Kang H; Lee HW; Bae SH; Lee JH; Paik YH; Lee JS
Korean J Intern Med; 2016 Jan; 31(1):46-53. PubMed ID: 26767857
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic role of serum glypican-3 in differentiating hepatocellular carcinoma from non-malignant chronic liver disease and other liver cancers.
Tangkijvanich P; Chanmee T; Komtong S; Mahachai V; Wisedopas N; Pothacharoen P; Kongtawelert P
J Gastroenterol Hepatol; 2010 Jan; 25(1):129-37. PubMed ID: 19793164
[TBL] [Abstract][Full Text] [Related]
33. Expressions of hypoxia-inducible factor-1 and epithelial cell adhesion molecule are linked with aggressive local recurrence of hepatocellular carcinoma after radiofrequency ablation therapy.
Yamada S; Utsunomiya T; Morine Y; Imura S; Ikemoto T; Arakawa Y; Kanamoto M; Iwahashi S; Saito Y; Takasu C; Ishikawa D; Shimada M
Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S436-42. PubMed ID: 24566861
[TBL] [Abstract][Full Text] [Related]
34. Significance of plasma osteopontin in diagnosis of hepatitis C virus-related hepatocellular carcinoma.
Nabih MI; Aref WM; Fathy MM
Arab J Gastroenterol; 2014; 15(3-4):103-7. PubMed ID: 25249230
[TBL] [Abstract][Full Text] [Related]
35. Cytokine evaluation in liver cirrhosis and hepatocellular carcinoma.
Cheng KS; Tang HL; Chou FT; Chou JW; Hsu CH; Yu CJ; Kao ST; Li TC
Hepatogastroenterology; 2009; 56(93):1105-10. PubMed ID: 19760951
[TBL] [Abstract][Full Text] [Related]
36. Detection of interleukin-33 in serum and carcinoma tissue from patients with hepatocellular carcinoma and its clinical implications.
Zhang P; Liu XK; Chu Z; Ye JC; Li KL; Zhuang WL; Yang DJ; Jiang YF
J Int Med Res; 2012; 40(5):1654-61. PubMed ID: 23206447
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of interleukin-6, interleukin-10 and human hepatocyte growth factor as tumor markers for hepatocellular carcinoma.
Hsia CY; Huo TI; Chiang SY; Lu MF; Sun CL; Wu JC; Lee PC; Chi CW; Lui WY; Lee SD
Eur J Surg Oncol; 2007 Mar; 33(2):208-12. PubMed ID: 17140760
[TBL] [Abstract][Full Text] [Related]
38. Human telomerase reverse transcriptase messenger RNA (TERT mRNA) as a tumour marker for early detection of hepatocellular carcinoma.
El-Mazny A; Sayed M; Sharaf S
Arab J Gastroenterol; 2014 Jun; 15(2):68-71. PubMed ID: 25097049
[TBL] [Abstract][Full Text] [Related]
39. High serum interleukin-6 level predicts future hepatocellular carcinoma development in patients with chronic hepatitis B.
Wong VW; Yu J; Cheng AS; Wong GL; Chan HY; Chu ES; Ng EK; Chan FK; Sung JJ; Chan HL
Int J Cancer; 2009 Jun; 124(12):2766-70. PubMed ID: 19267406
[TBL] [Abstract][Full Text] [Related]
40. The role of mean platelet volume in the diagnosis of hepatocellular carcinoma in patients with chronic liver disease.
Kurt M; Onal IK; Sayilir AY; Beyazit Y; Oztas E; Kekilli M; Turhan N; Karaman K; Akdogan M
Hepatogastroenterology; 2012; 59(117):1580-2. PubMed ID: 22683976
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]